Labcorp expanding bioanalytical service offering in the Asia-Pacific region with an integrated laboratory in Singapore
To meet the increased demand of pharmaceutical and biotechnology companies and drive continued growth, we are pleased to announce the expansion of its bioanalytical operations in Asia-Pacific. This new laboratory in Singapore will be co-located with its Central Laboratory Services.
The additional capacity in such a strategic and important region serves to strengthen our extensive global presence and offers in-region and international clients a complementary site in Asia-Pacific for support of their bioanalytical studies.
The Singapore-based bioanalytical laboratory will be a full service provider of regulated and non-regulated services supporting the development of both small and large molecular entities:
- Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)-compliant bioanalysis
- Liquid Chromatography Mass Spectrometry (LC-MS) and Immunochemistry platforms
- Discovery and clinical biomarker analytical services
- Synergy between Central Lab and Bioanalytical Lab
- Fast data turnaround for early phase trials in APAC
The expansion was led by Fan Jin, who is the APAC General Manager of Central Laboratories.
This laboratory is a reaffirmation of our commitment to continue our efforts in providing bioanalytical solutions to all our clients across this fast growing region by driving strategic partnerships, quality, and operational excellence.
Expanded operations for dependable delivery around the world
| United States | Europe | Asia Pacific |
| Salt Lake City, Utah Madison, Wisconsin Indianapolis, Indiana Chantilly, Virginia Somerset, New Jersey | Harrogate, UK Huntingdon, UK | Shanghai, China Singapore, SGP |
Learn more about our global bioanalytical capabilities at www.labcorp.com